The information contained in the Organizational Database (ODB) is provided for informational purposes only. There is no implied endorsement by NORD. NORD does not promote or endorse participation in any specific organization. The information is subject to change without notice. Every effort is made to ensure that the details for each entry are as current as possible.
The Psedohypoaldosteronism (PHA) Foundation is a group of patients and parents who support families with pseudohypoaldosteronism. This online group offers advice and support for those who have a possible diagnosis of PHA, new diagnosis of PHA or have been diagnosed with PHA long-term. The PHA Foundation has experience with PHA type 1 and type 2, as well as type 1 dominant and recessive. This online community also runs a closed group that is only open to patients and parents affected by PHA. This group serves the international PHA community and offers support in several languages. Pseudohypoaldosteronism (PHA) has a type 1 and type 2 genetic distinction. PHA1 is a disease that affects the regulation of sodium levels in the body. Renal PHA1 is characterized by loss of sodium in the kidneys and is not as severe. However, systemic PHA1 causes sodium loss in other organs and can cause severe deyhyration and failure to thrive. PHA2 is caused by loss of both sodium and potassium in the kidneys and other organs. Symptoms include highly acidic blood, nausea, vomiting, and muscle weakness.
The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and the credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions is strictly prohibited.
NORD's Rare Disease Information Database is copyrighted and may not be published without the written consent of NORD.